Dassault Systèmes (DSY) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
3 Feb, 2026Executive summary
Q3 2025 delivered 5% revenue growth and a 30.1% operating margin, with EPS up 10% to €0.29, driven by strong subscription and recurring revenue, especially in Industrial Innovation and 3DEXPERIENCE.
Recurring revenue reached 84% of software sales YTD, with subscription revenue up 16% and 3DEXPERIENCE cloud revenue up 36% in Q3.
Major contract wins included Ford, Stellantis, and AbbVie, with new AI and cloud offerings accelerating growth.
Full-year EPS growth target of 7–10% reaffirmed, while revenue growth outlook was adjusted to 4–6% due to Medidata softness and macro volatility.
Key growth drivers include momentum in cloud, AI-driven solutions, and SaaS adoption.
Financial highlights
Q3 2025 total revenue was €1.461 billion, up 5% in constant currency, with software revenue at €1.32 billion and operating margin at 30.1%.
Recurring revenue accounted for 84% of software revenue YTD; subscription revenue grew 16% in Q3.
Non-IFRS diluted EPS was €0.29 in Q3, up 10% year-over-year; net income (non-IFRS) for Q3 was €389.6M.
Cash and cash equivalents stood at €3.91 billion, with net cash position at €1.32 billion as of September 30, 2025.
Operating cash flow for the first nine months was €1.334 billion, with a cash conversion ratio above 90%.
Outlook and guidance
FY25 revenue growth outlook revised to 4–6% (from 6–8%), with non-IFRS EPS growth target maintained at 7–10%.
Q4 2025 revenue expected between €1.697–1.817 billion, with operating margin of 37.2–38% and EPS of €0.41–0.45.
Operating margin guidance for FY25 is 32.0–32.4%.
Cash conversion expected to improve to 84% in 2026 as SaaS adoption increases.
Tax rate assumptions: ~16.2% for Q4 and 17.3% for FY25.
Latest events from Dassault Systèmes
- Pascal Daloz succeeds Bernard Charlès, driving continuity in Industrial AI and 3D UNIV+RSES.DSY
Investor update23 Feb 2026 - FY25 revenue up 4% to €6,240M, strong recurring/cloud growth; FY26 targets 3–5% growth.DSY
Q4 2025 Investor Call11 Feb 2026 - FY26 targets 3–5% revenue growth, margin expansion, and strong ARR momentum.DSY
Q4 202511 Feb 2026 - Revenue and EPS rose, with robust cloud and 3DEXPERIENCE growth; outlook remains strong.DSY
Q2 20249 Feb 2026 - Q2 revenue up 6%, guidance reaffirmed, strong 3DEXPERIENCE and cloud growth.DSY
Q2 20259 Feb 2026 - 5% revenue growth, 30.1% margin, and strong subscription momentum despite Life Sciences headwinds.DSY
Q3 2025 Investor Call3 Feb 2026 - Revenue and EPS guidance lowered for 2024, but H2 outlook and strategic focus remain strong.DSY
Guidance3 Feb 2026 - Strong H1 growth from 3DEXPERIENCE and cloud, with robust outlook despite deal delays.DSY
Q2 2024 Investor Call2 Feb 2026 - Q3 revenue up 4% to €1.46B; EPS guidance reaffirmed, with Q4 growth acceleration expected.DSY
Q3 202418 Jan 2026